The public trading debut of medical supply giant Medline will go down as the biggest global IPO of 2025. That’s impressive in and of itself, but it’s even more impressive given that the company is not ...

Medline Inc. is guiding prospective investors to expect its IPO to price in the upper half of the marketed range. The initial public offering has drawn orders for about 10 times the number of shares ...

Medical product maker and distributor Medline (MDLN) is guiding prospective investors to expect its IPO to be priced at the upper half of the marketed range, Bloomberg News reported, citing people ...

Medline MDLN, a private equity-backed medical-surgical products provider, went public Tuesday in the largest IPO of the year, drawing strong investor demand. The Northfield, Il.-based company raised ...

Medline shares surged more than 40% in their hotly anticipated New York debut on Wednesday, valuing the medical supply giant at $54 billion in the largest US initial public offering since Rivian’s ...

Strategic exits in the private market have delivered weak outcomes over the past two years, sources tracking private equity deals said.

Dec 17 (Reuters) - Medical supply giant Medline's ‌shares rose 41% above their offer price in their hotly anticipated ‌New York debut on Wednesday, capping a strong year for new listings and fueling ...

In pushing ahead with its IPO, both Medline and investors that are supporting the deal upfront are looking past the negative impact of tariffs. Only 16% of Medline’s total cost of goods sold is ...

After a record 2025 with 373 listings raising ₹1.95 trillion, primary market activity slows sharply as subscriptions moderate, small- and mid-cap weakness weighs on sentiment, and analysts flag a ...

While the PhonePe DRHP did not specify the exact size of the IPO, it was expected to be in the range of Rs 12,000-13,000 crore.